<

ABSCIENCES (EPA:AB) AB Science announced today that results from masitinib study AB12003 in prostate cancer have been presented at the 2021 American Urological Association

Transparency directive : regulatory news

13/09/2021 18:04



Other stories

26/04/2024 01:24
26/04/2024 00:26
26/04/2024 03:31
25/04/2024 09:11
26/04/2024 00:00
26/04/2024 03:31
25/04/2024 23:14
25/04/2024 16:59
25/04/2024 22:00
25/04/2024 19:09
25/04/2024 17:46
25/04/2024 23:00
25/04/2024 23:26
25/04/2024 15:13
25/04/2024 20:55
26/04/2024 02:11
25/04/2024 23:23
25/04/2024 07:59
25/04/2024 19:34
26/04/2024 00:44
24/04/2024 09:06
25/04/2024 12:30
25/04/2024 22:59
26/04/2024 01:01
26/04/2024 03:40
25/04/2024 17:38
26/04/2024 04:28
26/04/2024 03:31
26/04/2024 00:07
25/04/2024 22:56
25/04/2024 21:00
25/04/2024 19:30
24/04/2024 07:30
25/04/2024 14:18
25/04/2024 15:13
26/04/2024 03:27
25/04/2024 06:00
24/04/2024 22:01